Sensitivity to Intravenous Nicotine: Genetic Moderators

NCT00969137 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

213

Enrollment

OTHER

Sponsor class

Conditions

Nicotine Dependence

Interventions

DRUG: saline
DRUG: Nicotine

Sponsor

Yale University

Collaborators

[object Object]